Artificial oxygen carriers: Cell-free hemoglobin solutions - Current status 2004;Künstliche sauerstoffträger: Hämoglobinlösungen - Stand 2004

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 40, Issue 1, 2005, Pages 38-45

  Standl, T ^a  

^a STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

Author keywords

Artificial oxygen carriers; Blood substitute; Cell free hemoglobin; Hemoglobin solution; Tissue oxygenation; Volume substitute

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; FLUOROCARBON; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; NITRIC OXIDE; OXYGEN; OXYGLOBIN; PEG HB; PHP; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMBIENT AIR; ANEMIA; ANIMAL EXPERIMENT; BACTERIAL TRANSMISSION; BLOOD GROUP ABO SYSTEM; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CELL FREE SYSTEM; CHEMICAL MODIFICATION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; ERYTHROCYTE MEMBRANE; HEMORRHAGIC SHOCK; HUMAN; IMMUNOMODULATION; ISCHEMIA; NEPHROTOXICITY; NONHUMAN; ONCOTIC PRESSURE; ORGAN PERFUSION; OXYGEN TRANSPORT; PRION DISEASE; REPERFUSION INJURY; ROOM TEMPERATURE; TISSUE INJURY; TISSUE OXYGENATION; VASOCONSTRICTION; VIRUS TRANSMISSION; ANIMAL; CHEMISTRY; METABOLISM; OXYGEN CONSUMPTION;

ANIMALS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; HEMOGLOBINS; HUMANS; OXYGEN CONSUMPTION; SHOCK, HEMORRHAGIC;

EID: 14544281538     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-825914     Document Type: Conference Paper

References (56)

1. Vamvakas EC, Taswell HF. Epidemiology of blood transfusion. Transfusion 1994; 34: 464-470
2. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003; 349: 1205-1206
3. Popovsky MA. Transfusion and lung injury. Transfus Clin Biol 2001; 8: 272-277
4. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ, Schildberg FW. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-1333
5. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187-204
6. Feola M, Simoni J, Dobke M, Canizaro PC. Complement activation and the toxicity of stroma-free hemoglobin solutions in primates. Circ Shock 1988; 25: 275-290
7. Lee R, Atsumi N, Jacobs EE, Austen WG, Vlahakes GJ. Ultrapure, stroma-free, polymerized bovine hemoglobin solution: evaluation of renal toxicity. J Surg Res 1989; 47: 407-411
8. Lipfert B, Standl T, Dullmann J, Helmchen U, Schulte am Esch J, Lorke DE. Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch. Lab Invest 1999; 79: 573-582
9. Mullon J, Giacoppe G, Clagett C, McCune D, Dillard T. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med 2000; 342: 1638-1643
10. Harringer W, Hodakowski GT, Svizzero T, Jacobs EE, Vlahakes G. Acute effects of massive transfusion of a bovine hemoglobin blood substitute in a canine model of hemorrhagic shock. Eur J Cardiothorac Surg 1992; 6: 649-654
11. Siegel JH, Fabian M, Smith JA, Costantino D. Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 1997; 42: 199-212
12. Standl TG, Reeker W, Redmann G, Kochs E, Werner C, Schulte am Esch J. Haemodynamic changes and skeletal muscle oxygen tension during complete blood exchange with ultrapurified polymerized bovine haemoglobin. Intensive Care Med 1997; 23: 865-872
13. Vlahakes GJ, Lee R, Jacobs EE, LaRaia PJ, Austen WG. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990; 100: 379-388
14. 2 carriers after 2 h of hemorrhagic shock in conscious hamsters. Am J Physiol 1997; 272: H525-537
15. Glasgow SC, Shah AS, Noone RB, Gottfried MR, Eachempati SR, Talarico TL, Vaslef SN. Comparison of various hemoglobin polyoxyethylene conjugate solutions as resuscitative fluids after hemorrhagic shock. J Trauma 2000; 48: 884-892
16. Slanetz PJ, Lee R, Page R, Jacobs EE, LaRaia PJ, Vlahakes G. Hemoglobin blood substitutes in extended preoperative autologous blood donation: an experimental study. Surgery 1994; 115: 246-524
17. Faivre-Fiorina B, Caron A, Fassot C, Fries I, Menu P, Labrude P, Vigneron C. Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs. Am J Physiol 1999; 276: H766-770
18. Buehler PW, Mehendale S, Wang H, Xie J, Li M, Trimble CE, Hsia CJC, Gulati A. Resuscitative effects of polynitroxylated αα-cross-linked hemoglobin following severe hemorrhage in the rat. Free Radic Biol Med 2000; 29: 764-774
19. Sherman IA, Dlugosz JA, Perelman V, Hsia CJ, Wong LT, Condie RM. Systemic hemodynamic and hepatic microvascular responses to a 33% blood volume exchange with whole blood, stroma-free hemoglobin, and oxypolyhemoglobin solutions. Biomater Artif Cells Immobilization Biotechnol 1993; 21: 537-551
20. Gulati A, Sharma AC, Burhop KE. Effect of stroma-free hemoglobin and diaspirin cross-linked hemoglobin on the regional circulation and systemic hemodynamics. Life Sci 1994; 55: 827-837
21. Dobschuetz von E, Hoffmann T, Messmer K. Diaspirin cross-linked hemoglobin effectively restores pancreatic microcirculatory failure in hemorrhagic shock. Anesthesiology 1999; 91: 1754-1762
22. Driessen B, Jahr JS, Lurie F, Griffey SM, Gunther RA. Effects of haemoglobin-based oxygen carrier Hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolaemia model. Br J Anaesth 2001; 86: 683-692
23. Strate T, Mann O, Kleinhans H, Schneider C, Knoefel WT, Yekebas E, Standl T, Bloechle C, Izbicki JR. Systemic intravenous infusion of bovine hemoglobin significantly reduces microcirculatory dysfunction in experimentally induced pancreatitis in the rat. Ann Surg 2003; 238: 765-771
24. Freitag M, Strate T, Schneider C, Knoefel WT, Izbicki J, Standl T, Schulte am Esch J. Isovolemic hemodilution with HES plus bovine hemoglobin HBOC-200 improves tissue oxygen tensions of the pancreas in comparison with HES or Ringer alone in acute severe porcine pancreatitis. Anästhesiol Intensivmed Notfallmed Schmerzther 2002; 43: 663
25. Budhiraja V, Hellums JD. Effect of hemoglobin polymerization on oxygen transport in hemoglobin solutions. Microvasc Res 2002; 64: 220-233
26. Page TC, Light WR, Hellums JD. Prediction of microcirculatory oxygen transport by erythrocyte/hemoglobin solution mixtures. Microvasc Res 1998; 56: 113-126
27. Standl T, Horn P, Wilhelm S, Greim C, Freitag M, Freitag U, Sputtek A, Jacobs EE, Schulte am Esch J. Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs [see comments]. Can J Anaesth 1996; 43: 714-723
28. Standl T, Lipfert B, Reeker W, Schulte am Esch J, Lorke DE. Acute effects of a complete blood exchange with ultrapurified haemoglobin solution or hydroxyethyl starch on liver and kidney in an animal model. Anästhesiol Intensivmed Notfallmed Schmerzther 1996; 31: 354-361
29. Standl T, Freitag M, Burmeister MA, Horn EP, Wilhelm S, Schulte am Esch J. Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs than do stored red blood cells. J Vasc Surg 2003; 37: 859-865
30. Horn EP, Standl T, Wilhelm S, Jacobs EE, Freitag U, Freitag M, Schulte am Esch J. Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis. Surgery 1997; 121: 411-418
31. Standl T, Horn EP, Burmeister MA, Bangert K, Reiter B, Jacobs EE, Schulte am Esch J. Bovine hemoglobin restores myocardial tissue tension in dogs with acute critical coronary stenosis and extended hemodilution. Anesthesiology 1999; 90: A697
32. Habler O, Kleen M, Pape A, Meisner F, Kemming G, Messmer K. Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis. Crit Care Med 2000; 28: 1889-1898
33. Rempf C, Burmeister MA, Bartsch-Zwemke S, Rehberg S, Standl T, Schulte am Esch J. Effect of prophylactic or therapeutic application of cell-free hemoglobin HBOC-200 on the severity of cardiac arrhythmias during myocardial ischemia-reperfusion in rats. Eur J Anaesthesiol 2003; 20 (Suppl): A9
34. Burmeister MA, Rempf C, Krause T, Tuszynski S, Standl T, Schulte am Esch J. Effect of prophylactic and therapeutic application of the hemoglobin solution HBOC-200 on the infarct size after myocardial ischemia and reperfusion in rats. Anästhesiol Intensivmed Notfallmed Schmerzther 2003; 44: 744
35. Cole DJ, Schell RM, Drummond JC, Reynolds L. Focal cerebral ischemia in rats. Effect of hypervolemic hemodilution with diaspirin cross-linked hemoglobin versus albumin on brain injury and edema. Anesthesiology 1993; 78: 335-342
36. Kasper SM, Walter M, Grune F, Bischoff A, Erasmi H, Buzello W. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83: 921-927
37. Standl T, Wilhelm S, Horn EP, Burmeister M, Gundlach M, Schulte am Esch J. Preoperative hemodilution with bovine hemoglobin. Acute hemodynamic effects in liver surgery patients. Anaesthesist 1997; 46: 763-770
38. Brauer P, Standl T, Wilhelm S, Burmeister MA, Schulte am Esch J. Transcranial Doppler sonography mean flow velocity during infusion of ultrapurified bovine hemoglobin. J Neurosurg Anesthesiol 1998; 10: 146-152
39. Standl T, Burmeister MA, Horn EP, Wilhelm S, Knoefel WT, Schulte am Esch J. Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br J Anaesth 1998; 80: 189-194
40. LaMuraglia GM, O'Hara PJ, Baker WH, Naslund TC, Norris EJ, Li J, Vandermeersch E. The reduction of the allogeneic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000; 31: 299-308
41. Levy JH, Goodnough LT, Greilich PE, Parr GVS, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr J, Vlahakes G. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124: 35-42
42. Schubert A, Przybelski RJ, Eidt JF, Lasky LC, Marks KE, Karafa M, Novick AC, O'Hara JF, Saunders ME, Blue JW, Tetzlaff JE, Mascha E. Diaspirin- crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: A multicenter, randomized, controlled, double-blinded trial. Anesth Analg 2003; 97: 323-332
43. Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G Jr. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. JAMA 1999; 282: 1857-1864
44. Saxena R, Wijnhoud AD, Carton H, Hacke W, Kaste M, Przybelski RJ, Stern KN, Koustaal PJ. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30: 993-996
45. Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, Moss GS. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998; 187: 113-122
46. D'Agnillo F, Chang TM. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 1998; 16: 667-671
47. Hertzman CM, Keipert PE, Chang TMS. Serum antibody titers in rats receiving repeated small subcutaneous injections of hemoglobin or polyhemoglobin: a preliminary report. Int J Artif Organs 1986; 9: 179-182
48. Estep TN, Gonder J, Bornstein I, Aono F. Immunogenicity of diaspirin cross-linked human hemoglobin solutions. Biomat Art Cells Immob Biotech 1992; 20: 603-609
49. White CT, Murray LJ, Smith DJ, Greene JR, Bolin RB. Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med 1986; 108: 132-137
50. Langermans JAM, Vuren-van der Hulst MEB, Bleeker WK. Safety evaluation of a modified hemoglobin solution (PolyHbXL) in a murine infection model. Artif Cells Blood Subs and Immob Biotech 1996; 24: 376
51. Soltero R, Leppaniemi A, Pikoulis E, Ratigan J, Waasdorp C, Malcolm D. Diaspirin crosslinked hemoglobin (DCLHb) increases rat skin wound breaking strength after hemorrhage. Artif Cells, Blood Substit, and Immob Biotechnol 1996; 24: 433
52. Hughes GS, Francom SF, Antal EJ, Adams WJ, Locker PK, Yancey EP, Jacobs EE. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 1995; 126: 444-451
53. Hughes GS, Antal EJ, Locker PK, Francom SF, Adams WJ, Jacobs EE. Physiology and pharmocokinetics of a novel hemoglobin-based oxygen carrier in human. Crit Care Med 1996; 24: 756-764
54. Carlucci F, Miraldi F, Barretta A, Marullo AGM, Marinello E, Tabucchi A. Preservation of myocardial energy status by bovine hemoglobin solutions during ischemia. Biomed Pharmacother 2002; 56: 247-253
55. Conhaim RL, Rodenkirch LA, Watson KE, Harms BA. Acellular hemoglobin solution enters compressed lung capillaries more readily than red blood cells. J Appl Physiol 2000; 89: 1198-1204
56. Bone HG, Schenarts PJ, Fischer SR, McGuire R, Traber LD, Traber DL. Pyridoxalated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic sheep. J Appl Physiol 1998; 84: 1991-1999